Phytochemical Name : 1,5,8-trihydroxy-3-methoxyxanthone (XD)

Properties Information
PhytoCAT-ID PhytoCAT-2000
Phytochemical name or plant extracts 1,5,8-trihydroxy-3-methoxyxanthone (XD)
PMID 33107489
Literature evidence Therapeutic potential of xanthones from Swertia chirata in breast cancer cells
IUPAC name 1,5,8-trihydroxy-3-methoxyxanthen-9-one
Phytochemicals’ class or type of plant extracts Xanthone
Source of phytochemicals or plant Extracts Swertia chirata
Geographical availability Assam, East Himalaya, Nepal, West Himalaya
Plant parts Aerial parts
Other cancers Breast cancer
Target gene or protein Bax, Bcl-2
Gene or Protein evidence The significant (P<0.001) augmentation of intracellular Bax:Bcl-2 ratio showed the stringent sensitivity of cancer cells toward apoptosis signal when treated with XD.
Target pathways NA
IC50 1 μM against MCF-7 5 μM against MDA-MB-231
Potency XD among the xanthones found in S. chirata exerted significant therapeutic potential by inducing ROS mediated apoptosis in breast cancer cells both in vivo and in vitro at a low dosage being non-toxic to normal cells. Therefore, XD may emerge as a key chemotherapeutic agent in the future, overcoming the limitations of conventional chemotherapy.
Cell line/ mice model MCF-7, MDA-MB-231, Ehrlich ascites carcinoma (EAC), a mouse transplantable breast carcinoma cell line
Additional information  Survivability of mice increased significantly when treated with XD compared to other xanthones and cisplatin. Significantly increased ROS and LPO were found in cancer cells as a result of XD treatment which was unaltered in normal cell line. XD induced DNA damage and apoptosis in cancer cell lines.
PubChem ID 5281623
Additional PMIDs 33112542
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:60447535-2
Safety From the preclinical aspect, our investigation showed xanthone to be non-toxic to mice. More detailed toxicity studies are needed to be performed in other rodent and non-rodent species.